Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion-Reference-Cited by-同舟云学术

Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion

Published:2023-05 Issue: Volume:161 Page:114433
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Díaz-Sánchez Estela,López-Salas Alexander,Mirchandani-Duque Marina,Alvarez-Contino Jose Erik,Sánchez-Pérez Jose Andrés,Fuxe Kjell,Borroto-Escuela Dasiel O.,García-Casares Natalia,Narváez Manuel

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference84 articles.

1. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease;Moreno-Jimenez;Nat. Med,2019

2. Response to Comment on "Impact of neurodegenerative diseases on human adult hippocampal neurogenesis";Terreros-Roncal;Science,2022

3. Neural circuitry-neurogenesis coupling model of depression;Kim;Int J. Mol. Sci.,2021

4. Memory enhancement with kynurenic acid and its mechanisms in neurotransmission;Martos;Biomedicines,2022

5. [Emotional and motivational functions of the prefrontal cortex];Watanabe;Brain Nerve,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats;Cells;2024-04-12

2. Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus;The FASEB Journal;2024-04-04

3. Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder;Expert Opinion on Therapeutic Targets;2024-04-02

4. Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus;Expert Opinion on Therapeutic Targets;2024-04-02

5. Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions;Behavioral and Brain Functions;2024-03-28